This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Latest Drug Company Deal Not Drawing Believers

Disappointment frosted over Wall Street with news of the proposed Monsanto (MTC)- Pharmacia & Upjohn (PNU) merger.

But that didn't stop investors from trying to make money off the news.

Volatility Index
Today % Change
24.18 +1.14
Source: ILX

"It's a combination of two weak companies," says Steven Eick with New York arbitrage shop Avery Partners. Rumblings about Monsanto shopping itself around had spread across the Street since the November news of the ever-complicated American Home Products (AHP)- Warner-Lambert (WLA) merger that has degenerated into a run at Warner-Lambert by Pfizer (PFE).

But sell-side research had hinted the best price for Monsanto would probably come if it axed itself into pieces, possibly fetching somewhere in the mid-50s, Eick said.

So news Monday of the proposed tie-up with Pharmacia "was not unexpected. In fact, it was sort of dreaded," he added.

Ewww gross! Wall Street screwed up its face at the deal as if the two ugly kids in the class had decided to go to the prom together. Monsanto stock sank 5 3/4 to 36; Pharmacia fell 4 1/16 to 46 7/16.



Put/Call Ratio
Today (Noon) Previous Close
0.35 0.34
Source: ILX
"It's tempting to get involved" in playing the Monsanto-Pharmacia deal using stock or options strategies, said Larry Garshofsky, a hedge fund manager and arbitrager in Los Angeles. "Whenever you see a stock down 5 in a 'merger of equals' situation, it can draw some attention -- maybe a third-party bidder." He has no position in either company.

"Generally, the market doesn't like mergers of equals because people are looking for premiums. You own a stock and hope for a takeout at a premium. Monsanto was a pretty pregnant situation" after the November American Home Products-Warner Lambert marriage proposal drew in Pfizer as a rival bidder . That resurrected Monsanto as a takeover target since it had a deal with American Home fall through earlier and investors saw the chance of it being rekindled.

"But this deal is a disappointment," he sighed. Moreover, the arb community, which makes its money by betting on the likelihood of mergers and takeover deals going through, has been burned recently by the canceled Alza (ALZA)- Abbott Laboratories (ABT) merger. "A lot of people were hurt by that."

Meanwhile, back at the ranch, what about Delta & Pine Land (DLP), with which Monsanto has had a questionable merger deal ?

Fading as fast as the 20th century, it seems. "It looks unlikely the stock will head back up anytime soon," said Craig Karsen with Eclipse, the Chicago-based designated market maker in Delta & Pine options.

But even on a deal that's largely viewed as soggy by most of the pros, there's a way to make money. Selling Monsanto put options is one.

A put option is a contract between the buyer and seller that gives the buyer the right to sell a stock or an index at a predetermined time in the future. A put seller, however, takes in a premium for accepting the obligation to buy a stock or an index at the strike price. The danger is that a stock gets "put" to the seller in the midst of a free fall and she ends up paying 70 for a stock, for example, that's heading toward 55.

Let's say an investor is willing to wager that the Monsanto-Pharmacia deal won't go through, but doesn't mind owning Monsanto stock anyway on the chance it could fetch 50 in a breakup. That investor could sell puts on Monsanto as an alternative strategy to playing the merger's outcome with stock. It can be a good move if an investor thinks pessimism is overdone on any particular situation.

"Selling out-of-the-money puts could be an interesting alternative if the deal gets terminated," said Michael Schwartz with CIBC Oppenheimer in New York. Currently Monsanto's January 30 puts are trading for 7/16 ($43.75), up 3/16 ($18.75) on slim volume, while the April 30 puts are trading at 1 ($100), up 7/16 ($43.75).

"Worst case, you own the stock at the strike price, minus the premium you took in for selling option. Best case, the stock never trades at or below the strike price," and the option expires worthless, Schwartz said.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs